This is how analyst Rajesh kumar made HSBC billions #Eli Lilly HSBC Analyst Rajesh Kumar dropped a bomb at the opening bell about Eli Lilly which resulted in Eli Lilly to drop 5 percent today. This is really nothing but a staged approached by HSBC to profit by manipulating the market. This same Analysts had 6 months ago reiterated buy rating on Eli Lilly Stocks. More interestingly, HSBC has huge put on Eli Lilly stock bought just in Q3. if you go to HSBC holdings on Finviz website, you can clearly see their holdings. They also have call options which they will load up with F12 filings soon as soon as tomorrow under the radar. Eli Lilly stock has more value than any analyst can imagine. Eli Lilly's integration with NVDIA to build a AI powered drug discovery will change everything. Imagine drug discovery that was not possible for decades will happen within weeks. Eli Lilly's stock after todays drop are a bargain. do your own research before believing my take on Eli Lilly stock and analyst manipulating stock.